Outpace Bio
Pre-clinicalRevolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance CAR-T therapy safety and efficacy.
Founded
2021
Focus
Cell & Gene Therapy
About
Revolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance CAR-T therapy safety and efficacy.
Funding History
2Total raised: $42.5M
Series A$30MDigitalis VenturesOct 15, 2023
Seed$12.5MDigitalis VenturesMay 15, 2022
Company Info
TypePrivate
Founded2021
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile